Advancements Expected to Accelerate Development of mRNA Therapeutics SAN DIEGO – TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids such as DNA and RNA, announced today that the United States Patent and Trademark Office has issued two new patents to the company. Both patents cover advancements in TriLink’s […]
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the International Trade Commission (ITC) affirmed the Administrative Law Judge’s finding that 10X Genomics infringed three of Bio-Rad’s patents. The Commission also issued a Limited Exclusion Order and Cease and Desist Order against 10X […]
Gives scientists a new view into natural cell activity, accelerating drug development MilliporeSigma, a leader in genome editing, today announced that it has signed a license agreement providing Promega Corp., a global life science manufacturer based in Madison, Wisconsin, access to MilliporeSigma’s foundational CRISPR intellectual property. Promega will use MilliporeSigma’s CRISPR genome-editing technology to create research products […]
Scientists will have new view into natural cell activity, accelerating drug development Madison, WI USA. Promega Corporation today announced it has signed a license agreement with MilliporeSigma, a leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome-editing technology. Under the agreement, Promega will create new research products for investigating endogenous biology, including those for drug […]
DARMSTADT, GERMANY Merck now holds 22 CRISPR-related patents worldwide across nine different geographies Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research Merck, a leading science and technology company, today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application […]
AbCellera Biologics Inc., a global leader in therapeutic antibody discovery from natural immune systems, today announced that the U.S. Patent and Trademark Office (USPTO) has granted patent no. 10,466,241 titled “Methods for Assaying Cellular Binding Interactions.” The patent, exclusively licensed to AbCellera, originated from Carl Hansen’s former laboratory at the University of British Columbia and lists Carl […]
The proposed merger of 2 DNA sequencing system firms, Illumina and PacBio, raises competition concerns, an in-depth CMA review has provisionally found. The Competition and Markets Authority (CMA) has issued its provisional findings as part of a Phase 2 merger investigation of the proposed $1.2 billion takeover by Illumina, Inc. (Illumina) of Pacific Biosciences of […]
Newly Allowed Patent Covers use of the CertainT ® Platform in Cellulosic Fibers and Materials including Rayon; Company Currently in Discussions with Leading Manufacturers STONY BROOK, N.Y. – Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing for product authenticity and traceability solutions, announced today that […]
DeNovix Inc. announced today that the CellDrop™ Automated Cell Counter, the first imaging cell counter to operate without the need for slides or plastic consumables, has been granted Patent No. 6579475 by the Japanese Patent Office (JPO). WILMINGTON, DE — DeNovix Inc. announces the award of Japanese Patent No. 6579475 covering their innovation in the […]
SAN JOSE, Calif. – Complete Genomics, a U.S. affiliate of MGI, has filed a patent infringement counterclaim against Illumina in U.S. District Court for the Northern District of California. The lawsuit, filed September 30, alleges that Illumina and its customers are using various gene sequencers and related reagents, including NovaSeq 6000, HiSeq X Ten, HiSeq 3000, and HiSeq 4000, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
